SRDX Stock Down Following Q2 Earnings Miss, Gross Margin Contracts

• click to rate

  Posted by Two Blokes May 1 - Filed in Stock - 0 views
  
  Despite the strength in Pounce thrombectomy device platforms and strong IVD product sales, Surmodics' second-quarter fiscal 2025 results show weak performance.